Literature DB >> 9809906

Atrial fibrillation trials: will they teach us what we need to know?

P R Kowey1, R A Marinchak, S J Rials, S Heaney, D B Bharucha.   

Abstract

Atrial fibrillation (AF) has captured the imagination of clinical investigators who have initiated trials to examine several aspects of this multifaceted arrhythmia. We will review the protocol designs of ongoing trials that are examining the relative value of rhythm versus rate control, new methods for pharmacologic restoration and maintenance of sinus rhythm (including prophylaxis after cardiac surgery), and nonpharmacologic interventions such as pacing and atrial defibrillation. We antic ipate that the results of these studies will have a major impact on the care of patients with AF in the new millennium.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9809906     DOI: 10.1016/s0002-9149(98)00741-3

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  3 in total

1.  Pharmacological atrial defibrillation via temporarily occluded coronary sinus: first clinical experience and implications for an implantable device.

Authors:  G Vergara; D Catanzariti; F Cozzi; R Accardi; W Spagnolli; L Cammilli
Journal:  J Interv Card Electrophysiol       Date:  2000-06       Impact factor: 1.900

2.  Transient ST Elevation in Vagally Mediated Atrial Fibrillation.

Authors:  Constantinos Makrides
Journal:  J Atr Fibrillation       Date:  2012-06-15

Review 3.  Cost effectiveness of therapies for atrial fibrillation. A review.

Authors:  M P Teng; L E Catherwood; D P Melby
Journal:  Pharmacoeconomics       Date:  2000-10       Impact factor: 4.981

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.